102P Long-term prediction of clinical outcomes by the 21-gene test in HR+ HER2- breast cancer patients with residual disease after neoadjuvant chemotherapy
Title:
102P Long-term prediction of clinical outcomes by the 21-gene test in HR+ HER2- breast cancer patients with residual disease after neoadjuvant chemotherapy
Author:
Peg, V. de los Ángeles, N. Vieites, B. Bellet, M. Castilla, C. Gomez Pardo, P. Pérez-Luque, A. Lopez, M.A. Salvador Bofill, F.J. Alfaro, L. Perez Garcia, J.M. Espinosa-Bravo, M.